Direct quantitation of serum high density lipoprotein subfractions separated by gradient gel electrophoresis. 1988

P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
Laboratoire de Biochimie Médicale, Faculté de Médecine, Dijon, France.

This report describes the densitometric quantitation of the two main HDL subfractions separated by electrophoresis in a polyacrylamide gradient gel, HDLS (mean apparent diameter 9.3 nm) and HDLL (mean apparent diameter 10.6 nm). The electrophoresis was carried out in a linear gradient of polyacrylamide ranging from 23 to 180 g/l on total sera prestained for lipid components by Sudan black B in ethylene glycol. HDL subfractions were quantified by scanning the gels at 633 nm with a laser densitometer. The precision was checked by intra-assay and between-assay studies (coefficient of variation 1.2 and 2.9%, respectively). The results were compared with the cholesterol content of HDL subfractions (r = 0.99) and with the HDL2:HDL3 distribution (r = 0.95). Reference values were obtained from a population of 214 normolipidemic subjects. They were in good agreement with those already published for HDL2 and HDL3. The method which needs only 4 microliter of serum, can be set up with currently available apparatus and is compatible with large series of samples, should allow large scale explorations of the variation of HDL subfraction distribution in normal and pathological populations.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D003720 Densitometry The measurement of the density of a material by measuring the amount of light or radiation passing through (or absorbed by) the material. Densitometries
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
July 1991, Clinical chemistry,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
December 1988, Biochemical genetics,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
April 1981, Acta medica Okayama,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
March 1992, Arteriosclerosis and thrombosis : a journal of vascular biology,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
January 1975, European journal of toxicology and environmental hygiene. Journal europeen de toxicologie,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
March 2003, American journal of clinical pathology,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
November 1985, Journal of lipid research,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
September 1994, Clinical chemistry,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
June 1993, The American journal of medicine,
P Gambert, and M Farnier, and C Bouzerand, and A Athias, and C Lallemant
September 1981, Biochimica et biophysica acta,
Copied contents to your clipboard!